Perseon Corp.’s MicroThermX microwave ablation system received 510(k) clearance from the FDA for the specific indication of laparoscopic ablation procedures using image guidance, the Salt Lake City, Utah, devicemaker announced today.
The device, featuring Synchronous Wave Alignment technology, consists of a single generator and an amplifier that deliver precision-guided microwave energy to up to three antennas, destroying cancerous soft tissue. The device has wheeled cart or tabletop versions.
The MicroThermX was launched in 2010 for soft tissue ablation, following FDA and CE Mark approval that year, a spokeswoman told Device Daily Wednesday.
Formerly BSD Medical, Perseon markets cancer treatment products in the U.S., Europe and Asia. — Jason Scott